Your shopping cart is currently empty

MC3138 is a selective SIRT5 activator showing antitumor effects in PDAC cells.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $39 | - | In Stock | |
| 5 mg | $89 | - | In Stock | |
| 10 mg | $139 | - | In Stock | |
| 25 mg | $278 | - | In Stock | |
| 50 mg | $455 | - | In Stock | |
| 100 mg | $689 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $98 | - | In Stock |
| Description | MC3138 is a selective SIRT5 activator showing antitumor effects in PDAC cells. |
| In vitro | MC3138 (10 μM, 24 h) inhibited lysine acetylation of GOT1 protein and decreased its enzyme activity in PDAC cells. Treated with MC3138 (50 μM, 24 or 48 h), MDA-MB-231 and CAL-62 cells, MC3138 reduced HIF-1α basal expression in MDA-MB-231 wt cells, but not in GLS1 silenced cells. [1] MC3138 decreased PDAC cell viability, with IC50 values ranging from 25.4 μM to 236.9 μM. [2] |
| In vivo | The maximum plasma concentration and half-life of MC3138 are approximately 230 μM and 5.059 hours, respectively. GOT activity was significantly reduced in PDX xenograft tumor mouse models treated with MC3138 (100-200 μM). [2] |
| Synonyms | MC 3138 |
| Molecular Weight | 435.47 |
| Formula | C25H25NO6 |
| Cas No. | 1844889-12-8 |
| Smiles | O=C(OCC)C1=CN(C=C(C(=O)OCC)C1C=2C=CC=C(OC)C2)C(=O)C=3C=CC=CC3 |
| Storage | keep away from moisture,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 50 mg/mL (114.82 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+90% Corn Oil: 5 mg/mL (11.48 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.